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Abstract 
 
Background and Purpose: The objective of this study was to compare the latest respiratory motion-management 
strategies, namely the internal-target-volume (ITV) concept, the mid-ventilation (MidV) principle, respiratory 
gating and dynamic couch tracking.  
Materials and Methods: An anthropomorphic, deformable and dynamic lung phantom was used for the 
dosimetric validation of these techniques. Stereotactic treatments were adapted to match the techniques and 
five distinct respiration patterns, and delivered to the phantom while radiographic film measurements were 
taken inside the tumor. To report on tumor coverage, these dose distributions were used to calculate mean doses 
(Dmean), changes in homogeneity indices (ΔH2-98), gamma agreement, and areas covered by the planned minimum 
dose (A>Dmin).  
Results: All techniques achieved good tumor coverage (A>Dmin>99.0%) and minor changes in Dmean (±3.2%). Gating 
and tracking strategies showed superior results in gamma agreement and ΔH2-98 compared to ITV and MidV 
concepts, which seem to be more influenced by the interplay and the gradient effect. For lung, heart and spinal 
cord, significant dose differences between the four techniques were found (p<0.05), with lowest doses for gating 
and tracking strategies.  
Conclusion: Active motion-management techniques, such as gating or tracking, showed superior tumor dose 
coverage and better organ dose sparing than the passive techniques based on tumor margins. 
 
  
Introduction 
 
The intra-fractional motion of lung tumors during radiotherapy treatment is strongly affected by respiration. 
Internal tumor motion larger than 30 mm in cranial-caudal direction has been reported [1]. This internal motion 
is a relevant uncertainty in radiotherapy, conventionally mitigated by extension of the target volume to cover 
the full motion envelope. As a consequence, this approach leads to higher radiation doses delivered to organs at 
risks (OARs). The management of respiratory motion, using breath-hold, beam gating or tracking techniques 
could lead to a desirable reduction in irradiation of OARs. In stereotactic body radiotherapy (SBRT), where high 
radiation doses are applied in a few fractions, this reduction might be beneficial to avoid increased toxicity to 
late-responding tissues associated with large fraction sizes. 
The four main motion-management strategies under free breathing are the internal-target-volume (ITV) concept, 
the mid-ventilation (MidV) principle, respiratory gating, and dynamic target tracking. For the ITV concept [2], the 
whole extent of tumor motion is taken into the safety margin. This increases the target volume but ensures 
tumor coverage. In the MidV principle [3], the tumor motion is assumed to be a random position error of the 
tumor. The safety margins are based on probability calculations and added to the tumor volume in the MidV 
position, resulting in smaller treatment volumes than the ITV concept. Using a gating approach [4, 5], the tumor 
is only irradiated in a predefined respiratory window with a smaller range of motion. This technique leads to a 
reduction of irradiated volumes but increases overall treatment time. Lastly, dynamic target tracking is the 
continuous compensation of tumor motion by either following the motion with the treatment beam, or shifting 
the patient position according to their internal tumor motion, keeping the tumor at the treatment isocenter. 
Former is commercially realized in the robotic CyberKnife system [6] and the Vero gimbaled linac system [7, 8]. 
Alternatively to these specialized treatment systems, tracking can also be integrated at conventional linear 
accelerators, which are widely used in clinics. This can be accomplished by either adapting the multi-leaf 
collimator, which is shaping the treatment field, to the changing target position (MLC tracking) [9, 10, 11], or by 
counter-steering the target motion with the treatment couch (couch tracking) [12, 13]. Tracking allows for a 
reduction of the treatment volume with continuous irradiation. Both gating and tracking require real-time 
information on the tumor position, whereas the ITV concept and the MidV principle are both passive motion-
management techniques based on the a priori extent of tumor motion. 
Interplay and gradient effects also influence the dose delivered to moving targets. The moving tumor 
accumulates dose irregularly since, firstly, the tumor moves through the inhomogeneously planned SBRT dose 
(gradient effect) and secondly, the motion of the MLC leaves coupled with the continuous gantry rotation 
interferes with the target motion (interplay effect). These effects additionally could be reduced by gating the 
treatment to a steady tumor position or tracking the moving tumor.  
Planning studies [14, 15, 8, 16] and phantom studies [17, 18] for comparisons between motion-management 
techniques have been performed previously. Planning studies are generally based on four-dimensional 
computed tomography data sets (4DCT), which provide patient-specific data for the dose calculation, but neglect 
actual capabilities of the delivery systems and are prone to motion artifacts [19]. The delivery capability of the 
techniques has only been reported in phantom studies with rigid, geometric phantoms. To date no study has 
compared all four techniques, nor has tumor coverage been considered as endpoint.  
In the present study, SBRT treatments adapted to all of the above-mentioned respiratory motion-management 
techniques were delivered to an anthropomorphic, dynamic thorax phantom [20]. The four techniques were 
compared in respect to tumor coverage and OAR dose sparing.  
 
Materials and Methods 
 
The phantom 
An anthropomorphic thorax phantom (LuCa) [20] was employed to simulate the anatomy and respiratory motion 
of a lung cancer patient (Figure 1). LuCa consists of an inflatable lung including a spherical wooden tumor (60 
mm) with two coronal planes for film inserts at 20 and 40 mm depth, and fitted to the size of the rigid tumor. 
Around the lung are a tissue-equivalent ribcage and a skin layer. A heart model, containing a film insert, is placed 
within the lung. The inflation of the lung is controlled externally with a ventilator, which follows any desired 
respiration pattern and directly influences the cranial-caudal tumor motion. This study was focused on known 
regular motion patterns. The following five respiration patterns were chosen for this study: The ventilator was 
operated with four regular curves following a sin or sin4, with a respiratory cycle period of 4 seconds and internal 
peak-to-peak motion amplitudes of 10 or 20 mm (10*Sin, 20*Sin, 10*Sin4 and 20*Sin4), and additionally with one 
curve following an irregular, patient-specific respiration pattern (Patient) with mean cycle period of 6.5 seconds 
and mean internal motion amplitude of 14 mm.  The shape of the internal motion trajectory differed slightly 
from the actual pressure input waveform due to hysteresis effects in the phantom [20]. 
 
Treatment planning 
The phantom was operated with the five respiration patterns while phase-sorted four-dimensional computed-
tomography (4D-CT) scans were taken with a SOMATOM Definition AS Open (Siemens AG, Germany) CT scanner. 
An average CT and ten breathing phases (phase CTs) were reconstructed using the RPM system (Varian Medical 
System, Palo Alto, CA). The gross tumor volumes (GTV) were delineated in all phase CTs. They were used to adapt 
the planning target volume (PTV) to match the five respiration patterns and the four investigated motion-
management techniques: 
- ITV concept: The entire tumor excursion, retrieved from the 4DCT, was contoured as internal target 
volume (ITV). A safety margin of 5 mm was added for the PTVITV.  
- MidV principle: The mid-position of the tumors from the 4DCT phases was estimated. The phase with 
the tumor closest to this mid-position was estimated and taken as GTVMIDV. The extent of tumor motion 
was retrieved from the 4DCT. Probabilistic margins based on the van-Herk formula [3] were added to 
the GTVMIDV to get the PTVMIDV. The margin recipe guaranteed that 90% of patients in the population 
receive a minimum cumulative GTV dose of at least 80% of the prescribed dose. 
- Gating: The gating window with a 30% duty cycle was set at end of inhale to maximize the tumor-heart 
separation and increased lung volume during irradiation. The residual motion within this gating window 
was retrieved from the 4DCT data set and later used as gating threshold. The tumor volumes of the 
corresponding three phases were added to the GTVGATE. A fixed 5-mm margin was added for the PTVGATE.  
- Tracking: GTVTRACK was also chosen to be the tumor volume closest to the mid-position, but a fixed 5-
mm margin was added for the PTVTRACK. 
Treatment plans for SBRT using volumetric modulated arc therapy were optimized with Eclipse, version 11.0.31 
(Varian Medical System, Palo Alto, CA), and doses were calculated with the analytical anisotropic algorithm (AAA) 
on the average CT. A dose of 8x6 Gy was prescribed to the 65% isodose line around the PTV, allowing for high 
dose increase towards the central part. Lung, heart and spinal cord were contoured as organs at risk (OAR) and 
spared as much as possible in the optimization process. The spinal cord was constrained to a dose maximum 
below 32 Gy [21]. All treatment plans consisted of four co-planar, full arcs with an avoidance sector to spare the 
contralateral side of the lung.  
 
Treatment delivery 
Treatments were delivered to LuCa using a TrueBeam linear accelerator (Varian Medical System, Palo Alto, CA). 
A 3D cone-beam CT was taken and a 6D match was performed to position the tumor isocentrically. For gating 
and tracking treatments, Calypso transponders (Varian Medical System, Palo Alto, CA) were inserted into the 
tumor, monitoring its motion in real-time. The tracking system latency, which includes the time needed for 
position detection, signal processing and final repositioning of the couch, was reported for the same couch 
tracking system to be in the range of 187 to 246 ms for sine motion patterns with periods from 8 to 2 seconds, if 
no motion prediction algorithm is used [22]. To mitigate the influence of the system latency, a fast Kalman 
prediction filter was applied to the input signal and the predicted tumor position was used for the application of 
tracking treatments. 
For the gating treatments, the residual motion measured in the phase-gating window at the planning stage was 
set as gating threshold. The Calypso signal triggered the irradiation only when the tumor position was within the 
threshold, prolonging the overall treatment time by a factor of 3. 
For the tracking treatments, the predicted tumor motion was compensated with the PerfectPitch treatment 
couch using the iTools Tracking software (Varian Medical System, Palo Alto, CA). Figure 2 shows the control loop 
for gating and tracking treatment delivery. 
In total, 24 treatments were measured, 20 for all combinations of respiration patterns and motion-management 
techniques, and additionally one static delivery for each technique. For each treatment, one fraction of 6 Gy was 
delivered and later scaled to a full treatment. 
 
Film measurements 
The dose was measured with Gafchromic EBT2 films (Ashland Inc., USA) inside tumor. The tumor films were 
placed in coronal direction and neatly covered the size of the tumor (58 mm diameter) at the inserts with 
approximately 1 mm accuracy. Each measurement was performed once with one film per insert. The irradiated 
films were scanned twice with an Epson scanner (Seiko Epson Corporation, Japan). The two scans were averaged 
to correct for scanning noise.  The green color channel of the film was converted to radiation dose in Matlab (The 
MathWorks Inc., USA) using a sheet specific five-step calibration set on the bottom of the sheet. A mean filter 
over 6x6 pixels (1.02x1.02 mm2) was applied to the measured film data to adjust for noise. To correct for intra-
sheet dose fluctuations, a homogeneously irradiated film sheet, irradiated with 7.6 Gy, was investigated. These 
fluctuations are caused by both film and scanner inhomogeneities. The homogeneously irradiated film was 
divided into 9 segments according to the tumor film positions on a film sheet. The mean dose in each segment 
was evaluated. Calibration factors were introduced to adjust the mean of each segment to 7.6 Gy. The inter-
sheet uncertainty was estimated by using two additional homogeneously irradiated film sheets and comparing 
the mean values of the segments after applying the same calibration factors. Differences were measured to 
be -0.4% ± 0.6% (mean ± std). Intra-segment dose variations were not addressed with this method. They showed 
1.4% (std) dose fluctuations over single segments.  
 
Dosimetric comparisons 
The four motion-management techniques were compared regarding tumor coverage and sparing of organs at 
risk with dose measurements and dose parameters from the treatment planning system. Dose was measured 
with film in the tumor and heart, and next to the spinal cord with a PinPoint ionization chamber (PTW-Freiburg 
GmbH, Germany).   
Firstly, the dose distributions in the tumor were analyzed. The 2D dose planes from the planned 3D dose 
distribution were taken at the position of both film inserts. Corresponding regions were taken for evaluation 
from the irradiated films and the planned doses. A margin of 2 mm at the film edged was excluded from the 
evaluation due to dose uncertainties at the film fringes and to exclude marks on the film which were used for 
alignment.  Near minimum (D99), near maximum (D1) and mean dose (Dmean) were retrieved and used for the 
calculation of homogeneity indices (H2-98 = 100*(D2-D98)/Dmean). The changes in homogeneity (ΔH2-98=H2-98,calc-H2-
98,meas) were reported. The areas of the films receiving more than the planned minimum dose (A>Dmin), and more 
than the prescribed 6 Gy (A>6Gy) were calculated. Gamma agreement scores (GI3%/2mm and GI5%/2mm) between the 
measured and the planned doses, with gamma criteria of 3%/2 mm and 5%/2 mm, were evaluated.   
Secondly, the dosimetric comparison of OARs was performed. Planned OAR dose parameters, as mean heart 
dose, maximal spinal cord dose (D0.5cc), mean lung dose (lung including tumor) and the lung volumes getting more 
than 5 or 20 Gy (V5Gy and V20Gy, respectively) were compared. For tracking, the intended shift of the phantom 
with the treatment couch was included in the planned OAR dose: The dose distribution of the tracking treatment 
plan was recalculated on each of the ten phase CTs, while the beam isocenter was shifted to the corresponding 
tumor isocenter. The summed-up dose was then displayed on the average CT. 
Additionally, the mean heart doses from the film measurements and the measured PinPoint doses were 
compared. 
 
Statistics 
The values were grouped according to their technique and compared with a Kruskal-Wallis test. The significance 
level for inequality of the groups was set to a p-value of < 0.05. The relations between motion amplitude and 
coverage parameters, and PTV size and organ doses were evaluated with Spearman rank correlations. 
 
Results   
 
Tumor coverage 
Tumor dose parameters are summarized in Table 1. Median values over all respiration patterns are listed 
together with 25% and 75% quartiles and the static delivery. All measured mean doses (Dmean) were all within 
±3.2% of the planned Dmean. Tracking and gating showed a tendency for higher measured than planned Dmean, 
while MidV and ITV showed mixed results.  
All techniques covered the tumor with the prescribed dose (A>6Gy = 100%) and showed adequately large areas 
covered by at least the minimum planned dose (A>Dmin>99.0%) for all techniques, except for two measurements 
of the MidV principle (94.8% and 97.7%). Deviations in homogeneity indices ΔH2-98 were found to be higher for 
the ITV and the MidV principle (medians: 4.3 and 5.6 pp, respectively) than for gating and tracking (2.8 and 2.3 
pp). However, the only parameter showing significance in the differences was ΔH2-98 (p<0.05). No significant 
correlations of these parameters with motion amplitude or pattern were found. 
 
Gamma agreement 
The gamma agreement scores GI3%/2mm and GI5%/2mm are listed in Table 1 and corresponding gamma maps with 
over- and underdosed areas are shown in Figure 3. The GI3%/2mm values for the ITV and the MidV principle 
(medians: 83.9% and 78.8%, respectively) were lower than for gating and tracking (90.2% and 88.2%), but without 
statistical significance. A significant negative correlation between the GI3%/2mm values and motion amplitude was 
found for the MidV (roh=-0.88, p<0.05) and tracking (roh=-0.88, p<0.05) cases, and between GI5%/2mm and motion 
amplitude for MidV (roh=-0.97, p<0.05). 
 
PTV reduction and OAR sparing 
The PTV size, normalized to the tracking case, and the organ dose parameters are shown in Figure 4. The values 
correspond to a full treatment course (8x6 Gy=48 Gy) and are shown as boxplots, grouped according to the 
applied motion-management techniques.  
A clear reduction of the target volume (PTV size) is visible from the ITV to the MidV principle, gating and tracking 
strategies. Similar reductions were found for organ dose parameters of the lung (lung Dmean, V20Gy and V5Gy), the 
spinal cord D0.5cc and the heart Dmean. Equality of the groups can be rejected with significance (p<0.05) for all OAR 
dose parameters. The reduction in OAR dose was significantly (p<0.05) correlated to the reduction in PTV size, 
as expected, with highest linear correlation coefficients for the lung Dmean, V20Gy and V5Gy (0.84, 0.73 and 0.95), 
spinal cord D0.5cc (0.77), and the planned and measured chamber dose (0.78 and 0.63). Lower correlation 
coefficients were found with the planned and measured heart Dmean (0.52 and 0.31), since it was only partially in 
the treatment fields. 
 
Discussion 
 
Patients with lung cancer and suboptimal respiration are at risk of acute and late radiation-induced toxicity. 
Motion-management techniques might thus allow decreasing the target volume and the radiation dose delivered 
to OARs, whilst delivering the full prescription dose to the target. This study investigated the dose delivery 
capability of the ITV concept, MidV principle, respiratory gating and dynamic couch tracking, and compared them 
in the lung phantom LuCa with regard to tumor coverage and organ dose sparing. 
So far, performance studies on motion management have employed geometrical, rigid motion phantoms whose 
main advantage is motion reproducibility, neglecting human anatomy. Falk et al. [17] used a Delta4 phantom 
(ScandiDos, Sweden) mounted on a motion platform to measure delivery performance of gating and tracking 
strategies. Menten et al. [18] simply used films within solid water, mounted on a motion platform, to compare 
accuracy of different tracking strategies. The phantom employed for this study resembles human anatomy and 
allows for any desired tumor motion in the cranial-caudal direction. The phantom’s components were chosen to 
have radiation-absorption properties equivalent human tissues. These anatomical features allowed using both 
OAR dose sparing and tumor coverage as endpoints.  
Overall, the active motion-management techniques, gating and tracking, showed better dose sparing than the 
passive techniques, ITV and MidV concept. This benefit is mainly caused by the reduction of treatment volume, 
which is largest for tracking. The observed reductions are comparable to those of other authors. Depuydt et al. 
[8] reported a PTV reduction of 35% when changing from the ITV concept to a tracking scenario, and 
Guckenberger et al. [16] showed a comparable decrease in lung Dmean, changing from ITV over to a MidV or gating 
approach.  
Although tracking allowed for the smallest PTV size, a benefit of gating over tracking was shown for heart Dmean 
and lung V20Gy (Figure 4). For gating, the potential reduction in OAR dose is also influenced by the choice of the 
gating window at exhale or inhale, which affects the separation between PTV and OARs.  In this work, a gating 
window at end of inhale was chosen. This yielded a bigger distance between the heart and the tumor, resulting 
in a sparing of the heart. Additionally, the dynamically changing isocenter was simulated for the tracking OAR 
dose. This results in a spread out of the target dose, and hence an increased lung V20Gy. 
It has to be mentioned, that the dose parameters of the lung were based on the lung volume including the tumor 
volume. The usual approach for reporting lung dose excluding the tumor volume would lead in this case to 
different lung volumes for each concept and motion trace and thereby bias the results. Additionally, the lung 
volume and shape of the phantom might not fully represent human beings. Consequently, the lung doses should 
rather be considered as an integral dose of the treatment and used as a relative evaluation between the 
techniques.     
The location of the tumor in the phantom was limited to a fixed location and size. We expect that our conclusions 
for the tumor coverage are independent of the location similar for the lung dose, but probably for the spinal cord 
the dose values may change, based on the location of the tumor.  
All techniques showed good tumor coverage (A>Dmin) with slightly inferior results for the MidV technique. This 
was expected, since a minimum of 80% coverage in 90% of all cases was assumed in the margin calculation.  
The lower pass rates (GI3%/2mm) and larger changes in homogeneity (ΔH2-98) found for ITV and MidV principles 
could be explained by the interplay and the gradient effect. As opposed to the gating and tracking techniques, 
the tumor changes its relation to the beam isocenter in ITV and MidV treatment. This makes the passive 
techniques more sensitive to interplay and gradient effects. For the gating and tracking treatments, both effects 
are negligible as long as the error in target localization and machine delay (detection and mitigation) are small. 
For larger system latencies, additional safety margins are required, which might reduce the benefit. 
The tracking system used a Kalman prediction filter, which reduces the effects of the system latency, but errors 
in the prediction might still impact the results. The Kalman filter predicts the signal linearly from the current 
speed and direction of the target assuming continued motion. This might lead to overshoots. Additionally, the 
couch motion is limited by acceleration speed, and therefore might have problems mitigating steep motion 
gradients. Hansen et al. [22] reported RMSE for the use of a fast Kalman filter, as it was applied in this work. A 
reduction in RMSE from 2.45 mm down to 0.85 mm was observed for lung motion curves when couch tracking 
was applied. 
This work focused on couch tracking as tumor tracking method. Other tracking systems are assumed to give 
similar benefits for tracking over other motion-management techniques. A multi-institutional study was 
performed by Colvill et al. [23] to compare real-time adaptive therapy with robotic, gimbaled, MLC and couch 
tracking. The four modalities were found to perform similarly on the 2%/2 mm and 3%/3 mm failure criteria.  
The Calypso transponders were inserted directly in the moving tumor, resulting in an ideal surrogate-to-tumor 
relation. In the clinical setting for lung cancer treatments, the transponders are normally implanted close to the 
tumor, in an accessible airway which may not move completely in phase with the tumor. Therefore, the phantom 
measurements might represent insufficiently cases with uncertainty in the surrogate-to-tumor relationship. 
Alternatively, externally-located surrogates combined with a correlation model can be used for position 
estimation [24]. However, external surrogates also increase the positional uncertainty due to potential deviations 
from the internal-to-external correlation model [25].   
A limitation of the LuCa phantom was the hysteresis between input pressure and actual tumor motion, due to 
which rapid accelerations of the tumor were possible [20]. Regarding the overall tracking latency of 200-300 ms, 
these steep motion gradients might not be properly compensated. The exponential sinusoidals (10*Sin4 and 
20*Sin4) showed some tracking errors at these gradients. However, all tracking measurements showed good 
tumor coverage. 
The Gafchromic films were placed in coronal planes at two different depths in the tumor. This coronal setup 
allowed capturing the motion effects in the pre-dominant cranial-caudal direction. However, the anterior and 
posterior edges of the tumor were not covered. But judging from the mainly longitudinal motion direction and 
rotational symmetry of the irradiation, it was assumed that those edges show similar behavior than the left and 
right edges, which were covered by the film. 
Gafchromic films have good spatial resolution, but are prone to noise and film inhomogeneities. Mean filters and 
inhomogeneity corrections were applied during the light-transmission-to-dose conversion of the green channel. 
The residual intra- and inter-sheet uncertainty of film measurements was estimated to be below 3%. Using two 
films per insert would further reduce the uncertainties and noise, and should be considered for further 
measurements. The Calypso system and cone beam CTs allowed setting up the tumor within 1 mm translational 
and 1° rotational offset to the reference position. The dose comparisons were made between doses measured 
in the phantom and 2D dose planes exported from the treatment plan. Additional factors as dose-calculation and 
machine uncertainties also influence the accuracy of these comparisons. The phantom’s lung tissue is of lower 
density than human lung tissue. This could be the reason that the dose estimated by the treatment planning 
system underestimated the GTV mean dose. The Calypso array further absorbs 1.5% to 2% of the radiation 
penetrating through it [26]. These effects together might explain the overall low GI as it can be seen in the static 
deliveries which yielded GI3%/2mm values around 92%. 
The study was limited to simple and mostly periodic respiration patterns in the cranial-caudal direction, and only 
single fractions were investigated. Single fraction deliveries represent the worst case scenario. Further work has 
to be done looking at the fractionation effect as well as looking at more complex motion patterns or motion 
patterns changing over the course of treatment. To better distinguish the benefit of one motion-management 
technique to another, additional measurements should be performed with larger variety of motion amplitudes 
and respiratory periods. For real patients, other sources of error, such as baseline shifts and changes in the 
respiratory motion characteristics over a course of treatment, have to be considered. Investigations into the 
robustness of the techniques with respect to these changes would be of high interest, but it is expected that 
under these conditions, tracking and gating with internal position markers would perform better than ITV and 
MidV. However, tracking accuracy is also limited by tumor deformations [27] if they are not considered in the 
planning process. For simplicity, the present work was performed with a rigid tumor. Deformations of the tumor 
volume could be considered by using a deformable tumor material, but challenges of dosimetry within deforming 
tissue have to be addressed.  
 
 
 
Conclusion 
The passive motion-management techniques (ITV and MidV) mitigated the motion with detectable, but 
clinically insignificant dose inhomogeneities. However, the larger treatment volumes incurred a penalty in the 
dose to organs at risk relative to gating and tracking. Beam gating based on the Calypso system provided good 
results in the measured endpoints. However, in this case, the overall treatment time increased by a factor of 3. 
On the other hand, the dynamic couch tracking was able to achieve adequate tumor coverage when compared 
to other respiratory motion-management techniques and at the same time was able to reduce the organ doses 
comparable to gating strategies, while no prolongation of delivery time was required. 
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Figures 
 
 
Figure 1: Average CT of LuCa with tumor, heart and Pinpoint: Transverse (A), coronal (B) and sagittal (C) plane. 
 
 
 
Figure 2: Control loop: The detected tumor motion (radiofrequency signal) is sent to the computer, which 
controls  i) the triggering of the beam for gating or ii) the countermotion with the treatment couch for tracking. 
 
 
Figure 3: Gamma maps of the anterior (top) and posterior (bottom) tumor films with 3%/2 mm and 5%/2 mm 
pass criteria, compared to the planned dose. Regions failing the gamma criterion are marked in black (higher) 
and white (lower dose than planned).  
 
 
Figure 4: PTV size, normalized to the tracking PTV (top left), and OAR dose parameters, shown as boxplots over 
the five respiration patterns, grouped according to the motion-management techniques (white: planned values, 
grey: measured values). Connections with grey brackets indicate groups with significantly different distributions 
(Kruskal-Wallis, p<0.05). 
Tables 
 
Table 1: Evaluated parameters from film measurements inside the moving tumor, representing the 
accumulated tumor dose, compared to the planned dose. 
 
ITV concept MidV Gating Tracking 
ΔDmean (Gy) 
0.01 (-0.03-0.21) 
[0.20] 
-0.04 (-0.11-0.16) 
[0.19] 
0.09 (0.03-0.12) 
[-0.12] 
0.16 (0.11-0.20) 
[0.09] 
A>Dmin (%) 
99.8 (99.6-99.9) 
[99.5] 
99.1 (97.0-99.5) 
[100] 
99.9 (99.4-99.9) 
[99.0] 
100 (99.9-100) 
[99.8] 
ΔH2-98 (pp) ° 
3.3 (3.0-3.7) 
[4.2] 
4.5 (2.9-5.8) 
[1.2] 
2.4 (2.0-3.4) 
[0.8] 
1.8 (0.6-2.0) 
[1.3] 
GS3%/2mm (%) 
83.9 (75.4-90.0) 
[93.9] 
78.8 (66.0-81.2) * 
[89.1] 
90.2 (85.5-91.2) 
[92.1] 
 88.2 (86.9-91.6) * 
[93.7] 
GS5%/2mm (%) 
93.1 (85.4-96.5) 
[98.2] 
91.4 (81.0-92.1) * 
[98.3] 
96.8 (96.0-97.3) 
[99.3] 
96.5 (96.1-97.2) 
[97.8] 
Values: Median (q25-q75), [static delivery], pp: percentage points, 
*: correlated to motion amplitude, °: significantly different between techniques 
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